Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of 9-valent HPV Vaccine in Healthy Adults
NCT03813940Phase 1Completed
- Sponsor
- Xiamen University
- Start
- Jan 2019
- Primary completion
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of Cecolin 9 in condylomata acuminata and Cervical Cancer (CC) (2 arms), sponsored by Xiamen University. Primary endpoints: Solicited local adverse reactions, Solicited systematic adverse reactions and 2 more. Started Jan 2019; status: completed.
02
Drugs
Cecolin 9
03
Conditions
condylomata acuminataCervical Cancer (CC)
Beyond the preview
Go deeper on NCT03813940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03813940.